FDA Approves Lillys Mounjaro for Heart Risk
The US FDA has approved Eli Lillys diabetes drug Mounjaro to reduce heart attack and stroke risks in adults with type 2 diabetes. The approval expands the treatments medical applications beyond standard blood sugar management.
Xurve View
Insights:
Xurve View